IPO
-
-
-
-
-
-
-
Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
-
-
-
-
-
-
-
Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease
-
-
-
-
-
-
-
Global Blood Therapeutics Appoints Philip A. Pizzo, M.D. to Board of Directors
-
-
-
-
-
-
-
Market Wrap: Markets Fend-off Further Yuan Slump; ITG Enters 'Dark Pool' Settlement; Cisco Ramps on Results; Pearson OKs Economist Group Sale
-
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

